Innovative Approaches to In Vitro Fertilization: Genomic Screening and Personalized Treatments for Enhanced Success Rates

Abstract

Background: In Vitro Fertilization (IVF) success remains a challenge despite significant advances. Innovative techniques, particularly genomic screening and personalized treatments, offer promising solutions to enhance success rates. Objective: To assess the impact of genomic screening and personalized IVF treatments on success rates, focusing on embryo selection, implantation rates, and pregnancy outcomes. Methods: This study was conducted at the Department of Gynecologic Surgery and Obstetrics, Uniformed Services University, Bethesda, USA, from January 2023 to December 2024. A total of 100 patients undergoing IVF were enrolled. Genomic screening, including preimplantation genetic testing (PGT), was performed to assess embryo viability and select the most viable embryos. Personalized IVF protocols were developed based on each patient’s genetic profile, age, and ovarian reserve. Embryo selection was guided by genomic and morphological assessments. Statistical analysis was performed using SPSS, with p-values set at <0.05. Results: The IVF success rate increased significantly from 45% (control group) to 68% in the personalized treatment group. The implantation rate was 63% for the genomic screening group, compared to 39% in the control group. The p-value for implantation success was 0.02, indicating significant improvement. Genomic screening led to a 15% higher pregnancy rate (p=0.03) compared to traditional methods. Standard deviation for pregnancy success rates was 5.4%. The personalized treatment approach resulted in improved embryo quality, with a 25% reduction in embryo aneuploidy (p=0.01). The ovarian reserve, as measured by Anti-Müllerian Hormone (AMH) levels, showed a positive correlation with IVF success (r = 0.68, p=0.01). Patients with a higher AMH level had a 20% increase in embryo quality. Furthermore, the miscarriage rate was reduced by 12% (p=0.04) in the genomic screening group compared to controls. Age-related success variation was also significant, with women under 35 having a 30% higher pregnancy rate (p=0.01). Conclusion: Genomic screening and personalized IVF protocols significantly enhance IVF success rates, embryo quality, implantation, and pregnancy outcomes. These results suggest a paradigm shift in assisted reproductive technologies.